32 articles for thisTarget

---

The following articles (labelled with PubMed ID or TBD) are for your review

PMID	Data	Article Title	Organization
26947959	35	Synthesis, structural characterization, docking, lipophilicity and cytotoxicity of 1-[(1R)-1-(6-fluoro-1,3-benzothiazol-2-yl)ethyl]-3-alkyl carbamates, novel acetylcholinesterase and butyrylcholinesterase pseudo-irreversible inhibitors.	University Of Pardubice
26632651	70	Novel Tacrine-Benzofuran Hybrids as Potent Multitarget-Directed Ligands for the Treatment of Alzheimer's Disease: Design, Synthesis, Biological Evaluation, and X-ray Crystallography.	China Pharmaceutical University
26363872	19	Synthesis and structure-activity relationship study of benzofuran-based chalconoids bearing benzylpyridinium moiety as potent acetylcholinesterase inhibitors.	Alzahra University
26260334	28	Galantamine derivatives with indole moiety: Docking, design, synthesis and acetylcholinesterase inhibitory activity.	Medical University Of Sofia
25017625	45	Synthesis and cholinesterase inhibition of cativic acid derivatives.	Universidad Nacional Del Sur
24835788	28	Preparation, anticholinesterase activity and molecular docking of new lupane derivatives.	Universidad Nacional Del Sur
18538575	3	Petrosamine, a potent anticholinesterase pyridoacridine alkaloid from a Thai marine sponge Petrosia n. sp.	Mahidol University
18479118	114	Exploiting protein fluctuations at the active-site gorge of human cholinesterases: further optimization of the design strategy to develop extremely potent inhibitors.	Universit£
17944454	34	First gallamine-tacrine hybrid: design and characterization at cholinesterases and the M2 muscarinic receptor.	University Of Bonn
15139762	133	Interaction of cycloSal-pronucleotides with cholinesterases from different origins. A structure-activity relationship.	University Of Hamburg
10052979	45	Aminopyridazines as acetylcholinesterase inhibitors.	Universit£
8978837	60	Structure-based alignment and comparative molecular field analysis of acetylcholinesterase inhibitors.	University Of North Carolina
8893840	12	The simulated binding of (+/-)-2,3-dihydro-5,6-dimethoxy-2-[[1-(phenylmethyl)-4-piperidinyl]meth yl] -1H-inden-1-one hydrochloride (E2020) and related inhibitors to free and acylated acetylcholinesterases and corresponding structure-activity analyses.	Eisai
19726199	30	Rational design and synthesis of highly potent anti-acetylcholinesterase activity huperzine A derivatives.	The Chinese Academy Of Sciences
	5	m-Alkyl, α,α,α-trifluoroacetophenones: A new class of potent transition state analog inhibitors of acetylcholinesterase	TBA
17317172	9	Methyl 2-(2-(4-formylphenoxy)acetamido)-2-substituted acetate derivatives: a new class of acetylcholinesterase inhibitors.	Sun Yat-Sen University
14584959	55	Molecular docking studies of natural cholinesterase-inhibiting steroidal alkaloids from Sarcococca saligna.	University Of Innsbruck
12729674	6	Synthesis, anticholinesterase activity and structure-activity relationships of m-Aminobenzoic acid derivatives.	Instituto PolitéCnico Nacional
9871563	31	Synthesis and activity studies of N-[omega-N'-(adamant-1'-yl)aminoalkyl]- 2-(4'-dimethylaminophenyl)acetamides: in the search of selective inhibitors for the different molecular forms of acetylcholinesterase.	Istituto Di Strutturistica Chimica G. Giacomello
26322521	6	Inhibition and Allosteric Regulation of Monomeric Phosphoenolpyruvate Carboxykinase by 3-Mercaptopicolinic Acid.	The University Of Kansas Medical Center
18849971	56	Targeted polypharmacology: discovery of dual inhibitors of tyrosine and phosphoinositide kinases.	University Of California San Francisco
18942826	19	Inhibitor Scaffolds for 2-Oxoglutarate-Dependent Histone Lysine Demethylases.	University Of Oxford
18227510	8	The T790M mutation in EGFR kinase causes drug resistance by increasing the affinity for ATP.	Harvard Medical School
17846131	15	Small-molecule scaffolds for CYP51 inhibitors identified by high-throughput screening and defined by X-ray crystallography.	University Of California San Francisco
18473434	57	Novel inhibitors of the v-raf murine sarcoma viral oncogene homologue B1 (BRAF) based on a 2,6-disubstituted pyrazine scaffold.	Cancer Research Uk Centre For Cancer Therapeutics
18925736	19	Structure-activity relationship studies of phenanthridine-based Bcl-XL inhibitors.	A* Star
18793847	33	Design and synthesis of 2-amino-pyrazolopyridines as Polo-like kinase 1 inhibitors.	Sunesis Pharmaceuticals